Live Breaking News & Updates on Shenzhen Yuanxing Gene Tech|Page 1

Stay updated with breaking news from Shenzhen yuanxing gene tech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Russia 'Unlikely' to Meet Promised 630M Target for COVID Vaccine Doses, Now Partnering with China


Russia Unlikely to Meet Promised 630M Target for COVID Vaccine Doses, Now Partnering with China
On 5/3/21 at 1:09 PM EDT
A London-based science analytics company, Airfinity, told the
Associated Press that it estimates Russia agreed to give 630 million doses of its homegrown vaccine to more than 100 countries but has exported only 11.5 million doses so far.
Moscow announced three deals totaling 260 million doses with Chinese vaccine companies in the past few weeks. The doses could reach countries in Latin America, the Middle East and Africa more quickly as a result of the partnership.
The partnership is also a benefit for both Russian and Chinese interests. Rasmus Bech Hansen, founder and CEO of Airfinity, said Russia is very ambitious and unlikely to meet their full targets. ....

United States , United Kingdom , South Korea , Helen Chen , Dmitry Peskov , Chen Dalin , Rasmus Bech Hansen , Hualan Bio , Shenzhen Yuanxing Co , Hualan Biological Bacterin Inc , Tibet Rhodiola Pharmaceutical Holding Co , Associated Press , Russian Direct Investment Fund , Latin America , Middle East , Bech Hansen , Shenzhen Yuanxing Gene Tech , Rhodiola Chairman Chen Dalin , Shenzhen Yuanxing , Economist Intelligence , Imogen Page Jarrett , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , தெற்கு கொரியா , ஹெலன் சென் , ரஸ்முச் பெச் ஹேன்சன் ,

Russian fund to increase Sputnik V production with China's company


Russian fund to increase Sputnik V production with China s company
Russian fund to increase Sputnik V production with China s company
Moscow, Apr 19 (Prensa Latina) The Russian Direct Investment Fund (RDIF) on Monday announced the cooperated production of more than 100 million doses a year of the Sputnik V vaccine in conjunction with Chinese company Hualan Biological Bacterin Co Ltd.
The manufacture of the Covid-19 vaccine will be carried out in the Chinese facilities of that company and will be used to immunize more than 50 million people, the Public Relations service of the Russian Fund pointed out. By late March, China s Shenzhen Yuanxing Gene-tech Co. also agreed to produce 60 million doses of the Sputnik V vaccine to fight the SARS-CoV-2 coronavirus, which causes the disease, in conjunction with the RDIF, which financed the development of the medicine. ....

Kirill Dmitriev , Temas Relacionados , Hualan Biological Bacterin Co Ltd , Russian Fund , China Shenzhen Yuanxing Co , Russian Direct Investment Fund , Prensa Latina , Public Relations , Shenzhen Yuanxing Gene Tech , Hualan Biological Bacterin , Executive Kirill Dmitriev , Sputnik V , ரஷ்ய நிதி , ரஷ்ய நேரடி முதலீடு நிதி , ப்ரெந்ஸ லத்தீன் , பொது உறவுகள் ,